Intratumoral CD16± Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

被引：14

作者：

Lee, Hansol ^{[1
,2
,3
]}

Ferguson, Angela L. ^{[2
,3
,4
,5
]}

Quek, Camelia ^{[1
,2
,3
]}

Vergara, Ismael A. ^{[1
,2
,3
]}

daSilva, Ines Pires ^{[1
,2
,3
,6
]}

Allen, Ruth ^{[2
,3
]}

Gide, Tuba Nur ^{[1
,2
,3
]}

Conway, Jordan W. ^{[1
,2
,3
]}

Koufariotis, Lambros T. ^{[7
]}

Hayward, Nicholas K. ^{[7
]}

Waddell, Nicola ^{[7
]}

Carlino, Matteo S. ^{[1
,8
]}

Menzies, Alexander M. ^{[1
,2
,8
,9
]}

Saw, Robyn P. M. ^{[1
,2
,9
,10
]}

Shklovskaya, Elena ^{[1
,11
]}

Rizos, Helen ^{[1
,11
]}

Lo, Serigne ^{[1
,2
]}

Scolyer, Richard A. ^{[1
,2
,3
,10
,12
]}

V. Long, Georgina ^{[1
,2
,3
,8
,9
]}

Palendira, Umaimaintha ^{[1
,2
,3
,4
,5
]}

Wilmott, James S. ^{[1
,2
,3
,13
]}

机构：

[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia

[3] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia

[4] Univ Sydney, Centenary Inst, Sydney, NSW, Australia

[5] Univ Sydney, Charles Perkins Ctr, Sch Med Sci, Infect Immun & Inflammat Theme, Sydney, NSW, Australia

[6] Westmead & Blacktown Hosp, Sydney, NSW, Australia

[7] QIMR Berghofer Med Res Inst, Herston, Qld, Australia

[8] Royal North Shore Hosp, Sydney, NSW, Australia

[9] Mater Hosp, North Sydney, NSW, Australia

[10] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[11] Macquarie Univ, Fac Med Hlth & Human Sci, Sydney, NSW, Australia

[12] NSW Hlth Pathol, Sydney, NSW, Australia

[13] Univ Sydney, Charles Perkins Ctr, Cent Clin Sch, Sydney, NSW 2037, Australia

来源：

CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 13期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

TUMOR-ASSOCIATED MACROPHAGES; CELL-MEDIATED CYTOTOXICITY; MONOCLONAL-ANTIBODY; T-CELLS; DEPENDENT CYTOTOXICITY; B-CELLS; RITUXIMAB; COMPLEMENT; EXPRESSION; CD16;

D O I：

10.1158/1078-0432.CCR-22-2657

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: This study characterizes intratumoral macrophage populations within baseline melanoma biopsies from patients with advanced melanoma who received either anti-PD-1 mono-therapy or a combination with anti-CTLA-4. Particularly, FcyRIIIa (CD16)-expressing macrophage densities were inves-tigated for associations with response and progression-free survival.Experimental Design: Patients with advanced melanoma who received either anti-PD-1 monotherapy or combination anti-PD-1 and anti-CTLA-4 were retrospectively identified. Macrophage populations were analyzed within baseline melanoma biopsies via multiplex IHC in relation to treatment outcomes.Results: Patients who responded to combination immune checkpoint inhibitor contained higher CD16 & PLUSMN; macrophage densities than those who did not respond (196 vs. 7 cells/mm2; P = 0.0041). There was no diffidence in CD16 & PLUSMN; macrophage densities in the PD-1 monotherapy-treated patients based on response (118 vs. 89 cells/mm2; P = 0.29). A significantly longer 3-year progression-free survival was observed in combination-treated patients with high intratumoral densities of CD16 & PLUSMN; macrophages compared with those with low densities (87% vs. 42%, P = 0.0056, n = 40). No association was observed in anti-PD-1 monotherapy-treated patients (50% vs. 47%, P = 0.4636, n = 50). Melanoma biopsies with high densities of CD16 & PLUSMN; macrophages contained upregulated gene expression of critical T-cell recruiting chemokines (CXCL9, CXCL10, and CXCL11). Conclusions: Our data demonstrate that tumor microenviron-ments enriched with CD16 & PLUSMN; macrophages are favorable for response to combination anti-PD-1 and anti-CTLA-4 therapy but not anti-PD-1 monotherapy. These data provides a potential biomarker of response for combination immunotherapies in patients with metastatic melanoma. See related commentary by Smithy and Luke, p. 2345

引用

页码：2513 / 2524

页数：12

共 46 条

[1] In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Arlauckas, Sean P.
Garris, Christopher S.
Kohler, Rainer H.
Kitaoka, Maya
Cuccarese, Michael F.
Yang, Katherine S.
Miller, Miles A.
Carlson, Jonathan C.
Freeman, Gordon J.
Anthony, Robert M.
Weissleder, Ralph
Pittet, Mikael J.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (389)
[2] Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
Balatoni, Timea
Mohos, Anita
Papp, Eszter
Sebestyen, Timea
Liszkay, Gabriella
Olah, Judit
Varga, Anita
Lengyel, Zsuzsanna
Emri, Gabriella
Gaudi, Istvan
Ladanyi, Andrea
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (01) : 141 - 151
[3] Complement, C1q, anc C1 q-related molecules regulate macropnage polarization
Bohlson, Suzanne S.
O'Conner, Sean D.
Hulsebus, Holly Jo
Ho, Minh-Minh
Fraser, Deborah A.
[J]. FRONTIERS IN IMMUNOLOGY, 2014, 5
[4] CD16 ON HUMAN GAMMA-DELTA LYMPHOCYTES-T - EXPRESSION, FUNCTION, AND SPECIFICITY FOR MOUSE IGG ISOTYPES
BRAAKMAN, E
VANDEWINKEL, JGJ
VANKRIMPEN, BA
JANSZE, M
BOLHUIS, RLH
[J]. CELLULAR IMMUNOLOGY, 1992, 143 (01) : 97 - 107
[5] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
Cartron, G
Dacheux, L
Salles, G
Solal-Celigny, P
Bardos, P
Colombat, P
Watier, H
[J]. BLOOD, 2002, 99 (03) : 754 - 758
[6] Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan
Chen, W.
Wang, J.
Jia, L.
Liu, J.
Tian, Y.
[J]. CELL DEATH & DISEASE, 2016, 7 : e2115 - e2115
[7] CLAASEN HHV, 1992, LAB INVEST, V67, P166
[8] Fc receptors are required in passive and active immunity to melanoma
Clynes, R
Takechi, Y
Moroi, Y
Houghton, A
Ravetch, JV
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 652 - 656
[9] Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
Dall'Ozzo, S
Tartas, S
Paintaud, G
Cartron, G
Colombat, P
Bardos, P
Watier, H
Thibault, G
[J]. CANCER RESEARCH, 2004, 64 (13) : 4664 - 4669
[10] Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies
Dechant, Michael
Weisner, Wencke
Berger, Sven
Peipp, Matthias
Beyer, Thomas
Schneider-Merck, Tanja
van Bueren, Jeroen J. Lammerts
Bleeker, Wim K.
Parren, Paul W. H. I.
van de Winkel, Jan G. J.
Valerius, Thomas
[J]. CANCER RESEARCH, 2008, 68 (13) : 4998 - 5003

← 1 2 3 4 5 →